✦ LIBER ✦
Initial experience with bosentan (Tracleer®) as treatment for pulmonary arterial hypertension (PAH) due to congenital heart disease in infants and young children
✍ Scribed by Gilbert, N. ;Luther, Y.-C. ;Miera, O. ;Nagdyman, N. ;Ewert, P. ;Berger, F. ;Lange, P. E. ;Schulze-Neick, I.
- Publisher
- Springer
- Year
- 2005
- Tongue
- German
- Weight
- 205 KB
- Volume
- 94
- Category
- Article
- ISSN
- 0300-5860
No coin nor oath required. For personal study only.